Onward Technologies reported 41% profit growth in Q2 FY27 and raised guidance. A ₹33 crore data-centre contract adds to its AI growth opportunity.
Objective response rate of 72.2% among response-evaluable patients receiving a starting dose of ≥450 mg at 32-week ...
Bristol Myers Squibb reported promising early MS CAR-T data (zola-cel) with 60 patients off medication, but disclosed one ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor ...
Hotel technology provider dailypoint has launched a free and anonymous AI Readiness Check for hotels. The initiative comes as ...
Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% ...
ZW191 demonstrates compelling anti-tumor activity in heavily pretreated patients with platinum-resistant ovarian cancer across folate receptor ...
Node.js released emergency patches for three versions to fix a critical Brotli compression library flaw (CVE-2026-111497) ...
With rising temperatures, the buttressing ice shelves at the edges the Antarctic ice sheet are melting and calving off at ...
Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment ...
BofA Global Research sees data center spending doubling to $2.1 trillion by 2028 on AI demand, at $49M per megawatt. Here is ...
Voyager Therapeutics, Inc. stays a Strong Buy as its dual Alzheimer’s programs near key 2026-2027 catalysts. Click for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results